This Top Paper Session by Armida Mucci, Spain, was recorded on 22 September 2024 at the 37th ECNP Congress in Milan, Italy.
Would you like to stay informed about the latest advancements in schizophrenia research? In this presentation, four key papers that were most clinically significant and at the forefront of the field over the past year are highlighted:
- Galderisi et al. (2024). Schizophrenia – Time to commit to policy change. Oxford Health Policy Forum.
- Solmi et al. (2024). Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators. European Neuropscychopharmacology.
- Vita et al. (2024). Conceptualization and characterization of ‘primary’ and ‘secondary’ cognitive impairment in schizophrenia. Psychiatry Research.
- Starzer et al. (2023). 20-year trajectories of positive and negative symptoms after the first psychotic episode in patients with schizophrenia spectrum disorder: Results from the OPUS study. World Psychiatry.
Views and opinions expressed in these videos are those of the presenters and do not necessarily reflect the official position of ECNP. The content of these videos should not be used in any way as the basis for treatment decisions.
